INT326282

Context Info Confidence 0.11 First Reported 2010 Last Reported 2010 Negated 0 Speculated 0 Reported most in Abstract Documents 1 Total Number 1 Disease Relevance 0.17 Pain Relevance 0

cytosol (BCL2L10) extracellular space (Pnlip) mitochondrion (BCL2L10) extracellular region (Pnlip) nucleus (BCL2L10) lipid metabolic process (Pnlip)

BCL2L10 (Homo sapiens) Pnlip (Rattus norvegicus)

Pain Link Frequency Relevance Heat anesthesia 1 5.00 isoflurane 1 5.00 Bioavailability 1 5.00

Disease Link Frequency Relevance Heat Obesity 6 91.04 Body Weight 3 42.00 Coronary Artery Disease 3 5.00 Disorder Of Lipid Metabolism 3 5.00 Dyslipidemia / Combined Dyslipidemia 1 5.00 Diarrhoea 1 5.00 Increased Venous Pressure Under Development 1 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

Dietary 1(3)-behenoyl-2,3(1)-dioleoyl-rac-glycerol (BOO) has been reported to inhibit pancreatic lipase activity in vitro and suppress postprandial hypertriacylglycerolemia in humans.

BOO Negative_regulation (inhibit) of pancreatic lipase

1) Confidence 0.11 Published 2010 Journal Lipids Health Dis Section Abstract Doc Link PMC2918615 Disease Relevance 0.17 Pain Relevance 0

General Comments

This test has worked.